AVITA Medical, Inc.

Healthcare · Medical Devices · United States

Last price 16.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 516.79M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting devi...